26 January 2008

New Alzheimer’s disease clinical study starting in Feburary 2008

Alzheimer’s disease, the commonest cause of dementia, affects millions of people world-wide. As yet no “cure” has been found, but several medications, of which donepezil (Aricept®) is the most frequently prescribed, are available to slow the degenerative process. Pharmaceutical companies are constantly conducting research in order to improve existing treatments or develop new medications.

The Sydney Centre for Clinical Cognitive Research at Prince of Wales Hospital is currently undertaking a pharmaceutical company sponsored study of a new slow-release formulation of donepezil and is seeking volunteers to participate.

People who would like to participate should be aged between 45 and 90 years, have a diagnosis of Alzheimer’s disease, have been on a single stable dose of 10mg donepezil (Aricept®) daily for at least 3 months and be prepared to be screened for eligibility.

The study will last 28 weeks and will involve 7 visits to our centre. Participants will receive routine physical and neurological examinations, blood tests and study medication at no cost. A partner/caregiver is required to attend all study visits with the participant. Travel expenses to study visits will be covered by the Sponsor.

If you are interested in participating in the above clinical trial and live in the Sydney area, please contact Lynne on (02) 9382-3733

No comments:

Post a Comment

Alzheimer's Australia NSW

Alzheimer's Australia NSW
Alzheimer's Australia NSW

Latest headlines from Library News

Library News

Total Pageviews